Data as of Nov 4, 2026.

vsOpen in the appCompare their flowsaskIQ about these two fundsAsk the committee about these two funds
Income ETFs

BIOY vs MDST: Dividend Yield & Total Return

Share
Share on XDownload as PDF

BIOY and MDST both write options for income.

askIQ about this page

askIQ about BIOY and MDST

Net assets: $1.5m on Nov 3, 2026 for GraniteShares YieldBOOST Biotech ETF, and $287m on Jul 31, 2026 for Westwood Salient Enhanced Midstream Income ETF.

At a glance
26.1%
BIOY cash paid, since launch, May 5, 2026
10.8%
MDST cash paid, 1 year
+5.4%
BIOY total return, since launch, May 5, 2026
+22.6%
MDST total return, 1 year
BIOY · since launch to Nov 4, 2026 13.6 pts behind XBI
BIOY
+5.4%
XBI
+19.0%

13.6 pts behind XBI

BIOY since launch: paid 26.1%, price −21.9%, total +5.4%, XBI +19.0%, −13.6 pts. Data to Nov 4, 2026.

XBI

+19.0%

BIOY

+5.4%

26.1% as cash

13.6 pts behind XBI

Total return, distributions reinvested

13.6 pts behind XBI

BIOY since launch: paid 26.1%, price −21.9%, total +5.4%, XBI +19.0%, −13.6 pts. Data to Nov 4, 2026.

XBI

+19.0%

BIOY

+5.4%

13.6 pts behind XBI

26.1% of it arrived as cash. Total return, distributions reinvested. BIOY since launch: paid 26.1%, price −21.9%, total +5.4%, XBI +19.0%, −13.6 pts. Data to Nov 4, 2026.

Data to Nov 4, 2026.
MDST · 1 year to Nov 4, 2026 9.1 pts behind ENFR
MDST
+22.6%
ENFR
+31.7%

9.1 pts behind ENFR

MDST over 1 year: paid 10.8%, price +11.5%, total +22.6%, ENFR +31.7%, −9.1 pts. Data to Nov 4, 2026.

ENFR

+31.7%

MDST

+22.6%

10.8% of it arrived as cash

9.1 pts behind ENFR

Total return, distributions reinvested

9.1 pts behind ENFR

MDST over 1 year: paid 10.8%, price +11.5%, total +22.6%, ENFR +31.7%, −9.1 pts. Data to Nov 4, 2026.

ENFR

+31.7%

MDST

+22.6%

9.1 pts behind ENFR

10.8% of it arrived as cash. Both charts share one scale, with zero at the line. MDST over 1 year: paid 10.8%, price +11.5%, total +22.6%, ENFR +31.7%, −9.1 pts. Data to Nov 4, 2026.

Data to Nov 4, 2026.

Pair scorecard

MDST costs 0.38 points a year less.

Points (pts) are percentage points.

BIOY vs MDST: Dividend Yield & Total Return
MeasureBIOYMDST
Paid and earned
Total return, 1 yearnot published+22.6%
Price changefell 21.9% (since May 5, 2026)rose 11.5% (1 year)
Return of capital, issuer estimate96% of the Sep 22, 2026 payment100% of the Oct 5, 2026 payment
Against its benchmark
BenchmarkBiotech, measured through XBIAlerian Energy Infrastructure ETF, measured through ENFR
Cost and size
Expense ratio1.18%0.80%
Net assets, BIOY as of Nov 3, 2026 and MDST as of Jul 31, 2026$1.5m$287m
Holdings
Holdings in common0%

Method

What they share

0%

By the books each fund has filed, BIOY and MDST hold 0% of their money in the same securities at the same weight. Holdings dated Jun 30, 2026 and Jul 31, 2026.

0 half 100%

half

0% in common

Positions both hold · largest shared weight first BIOY MDST
Only in one fund ↓
Only in BIOY
Only in MDST
ENERGY TRANSFER LP 9.17%
ENBRIDGE INC 8.76%
WILLIAMS COMPANIES INC (THE) 8.18%
ENTERPRISE PRODUCTS PARTNERS LP 6.85%
DT MIDSTREAM INC 6.08%
KINDER MORGAN INC 5.60%
CHENIERE ENERGY INC 4.90%
TC ENERGY CORP 4.82%
Check overlap with more funds →

Side by side

BIOY GraniteShares YieldBOOST Biotech ETF · Synthetic covered call on XBI, paying weekly MDST Westwood Salient Enhanced Midstream Income ETF · Option income on ENFR, paying monthly
Strategy synthetic covered call option income
Benchmark Biotech (XBI) Alerian Energy Infrastructure ETF (ENFR)
Pays weekly monthly
Payout rate, annualized 60.7% 9.7%
Expense ratio 1.18% 0.80%
Cash paid, 1 year 26.1% (since launch, May 5, 2026) 10.8%
Price change, 1 year −21.9% (since launch, May 5, 2026) +11.5%
Total return, 1 year +5.4% (since launch, May 5, 2026) +22.6%
Benchmark return, 1 year +19.0% (since launch, May 5, 2026) +31.7%
Ahead or behind −13.6 pts (since launch, May 5, 2026) −9.1 pts
Return of capital, latest estimate 96% 100%
Age 183 days 2.6 years
Net assets, BIOY as of Nov 3, 2026 and MDST as of Jul 31, 2026 $1.5m $287m

As of Nov 4, 2026. Source: ETFIQ. Cash paid: distributions over the window, as a share of the starting price. Payout rate: the latest payment, annualized, over today’s price.

Window by window

Window by window: BIOY vs MDST: Dividend Yield & Total Return
Total returnCash paidAgainst the benchmark
WindowBIOYMDSTBIOYMDSTBIOYMDST
3 months+6.9%−0.5%14.5%2.4%+2.9 pts+0.7 pts
6 months+4.4%+1.9%25.9%4.7%−11.3 pts+0.6 pts
1 year–+22.6%–10.8%–−9.1 pts
Since launchNot the same days: BIOY May 2026 · MDST Apr 2024+5.4%+44.5%26.1%27.9%−13.7 pts−21.5 pts

– means no data for this window. Open this comparison in the app →

Alert

The week's ETF fund flows, by email on Sundays.

One-click unsubscribe. See Privacy.

About each fund
BIOY

Over the period from its first trade on May 5, 2026 to Nov 4, 2026, BIOY paid 26.1% of its starting value in cash distributions while its price fell 21.9%. With every distribution reinvested, the fund returned +5.4%. Biotech (XBI) returned +19.0% over the same days, so a holder was behind by 13.6 pts. At its price on Nov 4, 2026 the latest distribution annualizes to 60.7%, paid weekly. GraniteShares estimates that 96% of the distribution paid Sep 22, 2026 was a return of capital (its 19a-1 notice). That is a tax label, not a measure of erosion.

MDST

Over the year to Nov 4, 2026, MDST paid 10.8% of its starting value in cash distributions while its price rose 11.5%. With every distribution reinvested, the fund returned +22.6%. Alerian Energy Infrastructure ETF (ENFR) returned +31.7% over the same days, so a holder was behind by 9.1 pts. At its price on Nov 4, 2026 the latest distribution annualizes to 9.7%, paid monthly. Westwood estimates that 100% of the distribution paid Oct 5, 2026 was a return of capital (its 19a-1 notice).

Questions people ask

Which is cheaper, BIOY or MDST?
BIOY charges 1.18% a year and MDST charges 0.80%, so MDST is cheaper. Fees come from each fund's prospectus.
Other comparisons
Cite this pageCitation, APA and Markdown

ETFIQ, BIOY against MDST, data as of Nov 4, 2026. https://etfiq.com/compare/income/bioy-vs-mdst

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.